GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Additional Paid-In Capital

Codexis (LTS:0I0X) Additional Paid-In Capital : $588.31 Mil(As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Codexis Additional Paid-In Capital?


Codexis's quarterly additional paid-in capital increased from Sep. 2023 ($581.84 Mil) to Dec. 2023 ($584.14 Mil) and increased from Dec. 2023 ($584.14 Mil) to Mar. 2024 ($588.31 Mil).

Codexis's annual additional paid-in capital increased from Dec. 2021 ($552.08 Mil) to Dec. 2022 ($566.08 Mil) and increased from Dec. 2022 ($566.08 Mil) to Dec. 2023 ($584.14 Mil).

Codexis Additional Paid-In Capital Historical Data

The historical data trend for Codexis's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Additional Paid-In Capital Chart

Codexis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 447.92 536.52 552.08 566.08 584.14

Codexis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 569.92 579.56 581.84 584.14 588.31

Codexis Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Codexis Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Codexis's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Codexis (LTS:0I0X) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Additional Paid-In Capital
Comparable Companies
ENGN RENB IMRX XOMA TSVT DRTS GOSS CRMD PBYI ALDX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XKRX:068270 BNTX ALNY
Traded in Other Exchanges
CDXS:USA 4QK:Germany
Address
200 Penobscot Drive, Redwood, CA, USA, 94063
Website
https://www.codexis.com
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines